HOSPITAL-ACQUIRED PNEUMONIA
Clinical trials for HOSPITAL-ACQUIRED PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new HOSPITAL-ACQUIRED PNEUMONIA trials appear
Sign up with your email to follow new studies for HOSPITAL-ACQUIRED PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic under watch: safety check after market launch
Disease control Recruiting nowThis study is monitoring the safety and real-world effectiveness of the antibiotic Zavicefta after its approval in Korea. It involves about 600 patients aged 3 months and older who are prescribed Zavicefta for serious infections like complicated abdominal infections, urinary trac…
Matched conditions: HOSPITAL-ACQUIRED PNEUMONIA
Sponsor: Pfizer • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
Herpes drug tested as potential lifesaver for ventilated pneumonia patients
Disease control Recruiting nowThis study aims to determine if treating herpes simplex virus (HSV) with the drug acyclovir helps critically ill pneumonia patients on ventilators survive. Researchers will randomly assign 616 ICU patients who have both pneumonia and HSV detected in their lungs to receive either …
Matched conditions: HOSPITAL-ACQUIRED PNEUMONIA
Phase: PHASE3 • Sponsor: Jena University Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC